q&a: autologous transplant for young standard-risk myeloma patients? - blood cancer onctalk 2023
Published 5 months ago • 28 plays • Length 8:20Download video MP4
Download video MP3
Similar videos
-
3:32
q&a: difference between autologous vs. allogeneic transplant in myeloma? - blood cancer onctalk 2023
-
7:23
autologous bone marrow transplants: use in myeloma and lymphoma - blood cancer onctalk 2023
-
3:53
identifying smoldering multiple myeloma patients: risk factors - blood cancer onctalk 2023
-
7:55
what is a bone marrow transplant? - blood cancer onctalk 2023
-
2:44
approaching treatment for smoldering multiple myeloma - blood cancer onctalk 2023
-
2:43
curative strategies for patients with smoldering multiple myeloma - blood cancer onctalk 2023
-
6:16
treatment options for multiple myeloma - blood cancer onctalk
-
2:44
the future of multiple myeloma treatment - blood cancer onctalk
-
6:06
immunotherapy in multiple myeloma: an overview - blood cancer onctalk 2023
-
4:10
what is smoldering multiple myeloma? - blood cancer onctalk 2023
-
6:45
approaches for treatment of multiple myeloma - blood cancer onctalk
-
2:26
risk adaptive management for high risk multiple myeloma - blood cancer onctalk
-
4:15
treatment timing for multiple myeloma - blood cancer onctalk
-
2:25
maintenance treatment in multiple myeloma - blood cancer onctalk
-
4:20
the spectrum of disease in multiple myeloma - blood cancer onctalk
-
3:41
cellular therapies in multiple myeloma - blood cancer onctalk
-
1:44
multiple myeloma - should everyone receive an autologous transplant?
-
2:28:27
vod 2023 blood cancer onctalk
-
3:53
the future of bispecific antibodies - blood cancer onctalk 2023